Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer

Sae-Ryung Kang,Ho Chun Song,Byung Hyun Byun,Jong Ryool Oh,Hyeon-Sik Kim,Sun-Pyo Hong,Seong-Young Kwon,Ari Chong,Jahae Kim,Sang-Geon Cho,Hee Jeong Park,Young-Chul Kim,Sung-Ja Ahn,Jung-Joon Min,Hee-Seung Bom

Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer

2014

Sae-Ryung Kang
Ho Chun Song
Byung Hyun Byun
Jong Ryool Oh
Hyeon-Sik Kim
Sun-Pyo Hong
Seong-Young Kwon
Ari Chong
Jahae Kim
Sang-Geon Cho
Hee Jeong Park
Young-Chul Kim
Sung-Ja Ahn
Jung-Joon Min
Hee-Seung Bom

Purpose We evaluated the value of variable 18F-FDG PET/CT parameters for the prediction of disease progression after concurrent chemoradiotherapy (CCRT) in patients with inoperable stage III non-small-cell lung cancer (NSCLC).

Keywords:

Radiology
Chemoradiotherapy
Pathology
Stage III Non-Small Cell Lung Cancer
Disease
Lung cancer
Medicine
Text mining
metabolic heterogeneity
disease progression
concurrent chemoradiotherapy
f 18 fdg pet
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations